CUTISS
Pablo Marty is a Research Associate at Cutiss AG since February 2021, previously serving as a Bewegungs- und Sportwissenschaftler at swissbiomechanics from February 2020 to January 2021. Pablo's academic background includes a Master's Thesis at the Institute of Biomechanics, focusing on "Bi-layered electrospun 3D skin models," aimed at developing a human skin model for drug testing and research on systemic sclerosis. Pablo holds a Master of Science degree in Health Science and Technology with a focus on Medical Technology, and a Bachelor of Science degree in Health Science and Technology, both from ETH Zürich.
CUTISS
CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDAOrphan drug designation for the treatment of burns.